By Larry Levitt
Source: The New York Times

Even in their pared-down form passed by Congress, the changes to the U.S. health care system in the Inflation Reduction Act are momentous, politically and for the many patients struggling with drug costs.

The Inflation Reduction Act is the biggest health reform initiative since passage of the Affordable Care Act, also known as Obamacare, more than a decade ago. And the fact that this new legislation passed despite the opposition of the drug industry — which, along with most insurance companies and hospitals, largely supported the A.C.A. — makes it, in a sense, even more of a statement about what’s politically possible in reforming the health system.

Read the full article